Mentor's synthetic pelvic prolapse mesh:
This article was originally published in Clinica
Executive Summary
Mentor has received US FDA 510(k) clearance to sell its first synthetic mesh product for treating pelvic organ prolapse, NovaSilk. The use of synthetic meshes for the treatment of pelvic organ prolapse represents one of the fastest growing segments of the women's health market, claimed the Santa Barbara, California firm, which already sells two human tissue-based products for the condition. NovaSilk comprises a macroporous, knitted, monofilament polypropylene mesh, while also being soft and light. It offers resistance to traction, allows tissue colonisation and facilitates positioning during surgery, the company said. According to Mentor, pelvic organ prolapse is estimated to afflict around 36 million women in the US and Europe.